Literature DB >> 19267176

Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.

Fatma Varol Tas1, Taner Guvenir.   

Abstract

In this article, our aim was to share our clinical experience regarding the effectiveness and the side effects of amisulpride treatment in adolescent cases. We reviewed all the cases who had amisulpride treatment during their stay in a newly opened in-patient unit, and three female cases who had undergone amisulpride treatment. We observed that the drug was effective and caused side effects like galactorrhea due to increased prolactin levels, which were not severe enough to terminate the treatment. Our clinical experience provides preliminary evidence that amisulpride might be an effective antipsychotic drug for adolescent cases. However, it caused considerable side effects.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19267176     DOI： 10.1007/s00787-009-0009-8

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


  8 in total

1.  Long-term safety and efficacy of amisulpride in subchronic or chronic schizophrenia. Amisulpride Study Group.

Authors:  L Colonna; P Saleem; L Dondey-Nouvel; W Rein
Journal:  Int Clin Psychopharmacol       Date:  2000-01       Impact factor: 1.659

2.  Amisulpride vs. risperidone in chronic schizophrenia: results of a 6-month double-blind study.

Authors:  Daniel Sechter; Joseph Peuskens; Odile Fleurot; Werner Rein; Yves Lecrubier
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

3.  Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.

Authors:  Matthias J Müller; Hermann Wetzel; Franz-Xaver Eich; Werner Rein; Alain Puech; Otto Benkert
Journal:  J Clin Psychopharmacol       Date:  2002-12       Impact factor: 3.153

Review 4.  Amisulpride: a review of its use in the management of schizophrenia.

Authors:  Kate McKeage; Greg L Plosker
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials.

Authors:  Peter S Jensen; Jan Buitelaar; Gahan J Pandina; Carin Binder; Magali Haas
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-10-30       Impact factor: 4.785

6.  A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.

Authors:  Ann Mortimer; Stephen Martin; Henri Lôo; Joseph Peuskens
Journal:  Int Clin Psychopharmacol       Date:  2004-03       Impact factor: 1.659

7.  Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.

Authors:  René S Kahn; W Wolfgang Fleischhacker; Han Boter; Michael Davidson; Yvonne Vergouwe; Ireneus P M Keet; Mihai D Gheorghe; Janusz K Rybakowski; Silvana Galderisi; Jan Libiger; Martina Hummer; Sonia Dollfus; Juan J López-Ibor; Luchezar G Hranov; Wolfgang Gaebel; Joseph Peuskens; Nils Lindefors; Anita Riecher-Rössler; Diederick E Grobbee
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

8.  The use of amisulpride in the treatment of acute psychosis.

Authors:  Philippe Nuss; Martina Hummer; Cédric Tessier
Journal:  Ther Clin Risk Manag       Date:  2007-03       Impact factor: 2.423
  8 in total
  1 in total

Review 1.  Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis.

Authors:  Siddharth Sarkar; Sandeep Grover
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.